Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
about
Cancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentPeroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerA paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapyTumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomographyMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesDual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotiniEpidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.Recent treatment advances and novel therapies in pancreas cancer: a review.Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.Smarter drugs emerging in pancreatic cancer therapy.Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla.Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancerEGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.The double trouble of metabolic diseases: the diabetes-cancer link.The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cellsIncreased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus.Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerThe Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature reviewIFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells.Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.What's new in treatment of pancreatic cancer: a patent review (2010-2017).Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma.IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer.Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis.Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling.Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.Differential expression of aquaporin-3 and aquaporin-5 in pancreatic ductal adenocarcinoma.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins.
P2860
Q26740619-B4421577-5FAB-4DF5-A6D6-324ADD02D963Q26764921-836B7F14-1C81-4FA8-91CF-A5B61F281075Q26824462-29C36C77-8AB5-42CE-ACE2-A02A86FE17D7Q27304350-FE1E8F2E-9245-4AF4-BDD4-E0AB70BB3167Q30354223-8ED44851-1D83-4595-921A-2A07C5334526Q33416585-A829F812-6285-4F4F-A645-E1EE52B67D42Q33556032-0EEDD6BB-F4A0-4E8D-B6A5-1A37CB45A4C7Q33625168-58CFB2CE-5218-402F-ABC7-EF6614A47C68Q34243313-65FF0066-2C20-44CB-8290-1F9084DE2D2FQ34410212-00E9B434-7E17-4CBB-B14C-EE919A3CE88CQ34472484-A44220DE-3EEC-4CD9-AF3F-B1DB72541C7BQ35095399-74041728-1F30-46B3-87A7-4233B132BC91Q35131201-93430685-A498-40DF-A28D-AEF128A7BFE6Q36014381-52430886-BACC-497D-8737-0C7DC2846753Q36058422-183B686C-9B34-4C54-81A4-B6CBC0CC4F9DQ36200253-448AC17A-546D-40D2-BA78-0C5C0E0B33B1Q36356248-4ADD9F03-2990-4C1D-8DF8-F8B07E903D93Q36456052-4C9948D7-09F3-421F-BF52-9F35E89085F5Q36677934-1F07491C-07C9-4F52-B4FB-30ED2B9EC488Q36980480-6962D9C5-D281-40CC-B54C-1FA95839136DQ37007341-0F64F1EF-2E37-4C05-B901-93C5F18B2E6EQ37134542-57056571-769C-49F3-9E0B-53DA83BB054DQ37681051-4ACE6443-F001-4557-A927-22C8F0B2F5B1Q38652339-67FC2C56-371B-4CE3-86C6-2DC21260AE03Q38844045-F51386E2-8C13-44E1-8AA1-4B11024272ABQ38914626-6ECADBB9-7DD2-443B-857F-EB9706AE3C11Q39028976-FE6FF938-CA38-4F04-A5E6-8D3610DEC336Q39406815-4935C056-08C1-4DBC-92B1-CC4B16C3AC56Q40610844-814B32B3-8984-4237-A0DA-96B03B25CE44Q41303851-BC0A72A0-5F4C-4CC1-81C5-DD0B326B5272Q42107855-87873DE9-2992-4F45-A61E-A5A0557AC286Q42576914-2B0E05B6-DCD4-4790-81CC-104B6FE9D267Q43872838-315F8CDE-024D-4B49-BEEA-1D689CDF62FAQ44636888-71FEBF36-9821-40A5-A256-3534062C82E1Q47141971-AB574B8C-6763-4ABC-BE1F-5905A4FCA555Q47758797-16C8282C-D224-4A00-9D9F-4F398F56AB7AQ48192181-CCDE04B2-D35E-43F6-80EF-1ED1B8BEEC10Q50314975-6C466DB7-5464-4806-ABE4-474A22674EACQ50857158-F40C9A0D-ADDA-4A56-B41C-C37A131C70C5Q53247248-176C62C8-D7C9-41C4-9C11-56E73402B7E1
P2860
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@en
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@nl
type
label
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@en
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@nl
prefLabel
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@en
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Epidermal growth factor recept ...... creatic ductal adenocarcinoma.
@en
P2093
Agnieszka K Witkiewicz
Boris Freydin
Charalambos Solomides
Charles J Yeo
Jonathan R Brody
Mary McDonald
Matias E Valsecchi
Stephen C Peiper
Terry Hyslop
P2860
P304
P356
10.1002/CNCR.26661
P407
P577
2011-11-15T00:00:00Z